JULIA NIEMI: Open Payments
NPI 1750807186 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 25 payments from 9 companies in 2025. Trend: 2023 $372 · 2024 $662 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $278 |
| Neurocrine BioSciences, Inc. | 2 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $97 |
| ABBVIE INC. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Exact Sciences Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: Ozempic, INGREZZA, JARDIANCE, Wegovy, VRAYLAR, Kerendia, The Cologuard Plus Collection Kit, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
